D. Mark

D. Mark, J. Blumenthal, M. Newman, 1999, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Acute Coronary Care

Daniel B. Mark, Robert M. Califf, Galen S. Wagner, 1985, Springer US.

Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns

D. Mark, L. Newby, P. Armstrong, 2005, Heart.

The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study

D. Mark, B. Gersh, N. Sotoodehnia, 2017, Journal of the American Heart Association.

Clinical and economic lessons from studies of coronary thrombolysis.

D. Mark, 1995, Journal of vascular and interventional radiology : JVIR.

Prognostic value of the simplified Selvester QRS score in patients with coronary artery disease.

F. Harrell, R. Califf, R. Ideker, 1988, Journal of the American College of Cardiology.

Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease.

R. Califf, D. Mark, Robert M. Califf, 1997, American heart journal.

Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).

G. Lamas, D. Mark, J. Hochman, 2011, American heart journal.

Effects of Coronary Angioplasty, Coronary Bypass Surgery, and Medical Therapy on Employment in Patients with Coronary Artery Disease: A Prospective Comparison Study

R. Califf, D. Pryor, D. Mark, 1994, Annals of Internal Medicine.

Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.

R. Califf, D. Mark, P. Armstrong, 2003, American heart journal.

A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications.

R. Califf, D. Mark, P. Armstrong, 1999, Journal of the American College of Cardiology.

Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators.

R. Califf, D. Mark, E. Topol, 1997, The American journal of cardiology.

A simplified method to predict occurrence of complete heart block during acute myocardial infarction

G. Lamas, R. Califf, D. Mark, 1986 .

Evaluating the Potential ‘Economic Attractiveness’ of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome

R. Califf, D. Mark, J. Jollis, 2000, PharmacoEconomics (Auckland).

Health Economics of Acute Coronary Syndromes

D. Mark, E. Peterson, 1998, Journal of Thrombosis and Thrombolysis.

Assessing the Clinical and Economic Burden of Coronary Artery Disease: 1986-1998

V. Hasselblad, K. Anstrom, D. Mark, 2001, Medical care.

Personality and Coping with a Common Stressor: Cardiac Catheterization

D. Mark, H. Bosworth, J. Feaganes, 2001, Journal of Behavioral Medicine.

Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.

R. Califf, D. Mark, P. Armstrong, 2004, American heart journal.

Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application

Jeffrey G. Gray, Eric L. Eisenstein, Eric D. Peterson, 1997, AMIA.

Hostility, age, and mortality in a sample of cardiac patients.

D. Mark, B. Brummett, S. Boyle, 2005, The American journal of cardiology.

Hostility as a Predictor of Survival in Patients With Coronary Artery Disease

D. Mark, B. Brummett, S. Boyle, 2004, Psychosomatic medicine.

Characteristics of Socially Isolated Patients With Coronary Artery Disease Who Are at Elevated Risk for Mortality

R B Williams, D. Mark, H. Bosworth, 2001, Psychosomatic medicine.

Social Support and Hostility as Predictors of Depressive Symptoms in Cardiac Patients One Month After Hospitalization: A Prospective Study

D. Mark, H. Bosworth, B. Brummett, 1998, Psychosomatic medicine.

Clinical characteristics and long-term survival of patients with variant angina.

F. Harrell, K. Lee, R. Califf, 1984, Circulation.

Medical economics and the assessment of value in cardiovascular medicine: Part I.

D. Mark, M. Hlatky, 2002, Circulation.

Female Gender Is Associated With Impaired Quality of Life 1 Year After Coronary Artery Bypass Surgery

W. White, D. Mark, K. Welsh-Bohmer, 2003, Psychosomatic medicine.

Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making.

V. Hasselblad, R. Califf, D. Mark, 2003, European heart journal.

Optimising outcomes: socioeconomic perspective

D. Mark, 1999, Heart.

Costs of interventional cardiac procedures.

D. Mark, 1994, Journal of interventional cardiology.

Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada: Comparison of Patients Enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I

R. Califf, D. Mark, E. Topol, 2004, Circulation.

Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada

R. Califf, D. Mark, E. Topol, 2004 .

Empirical estimation of life expectancy from large clinical trials: Use of left‐truncated, right‐censored survival analysis methodology

A. Tsiatis, D. Mark, C. Nelson, 2008, Statistics in medicine.

Effect of gender on angioplasty outcome: are we closer to the answer?

D. Mark, K. Alexander, 1997, Mayo Clinic proceedings.

Risk stratification in patients with chest pain.

D. Mark, 2001, Primary care.

Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment?

K. Lee, R. Califf, D. Pryor, 1992, Annals of internal medicine.

Assessing the Economic Attractiveness of Coronary Artery Revascularization in Chronic Kidney Disease Patients

Kevin J. Anstrom, Eric L. Eisenstein, Daniel B. Mark, 2009, Journal of Medical Systems.

Changing Efficacy of Coronary Revascularization

F. Harrell, R. Califf, D. Mark, 2005 .

Obesity and long-term clinical and economic outcomes in coronary artery disease patients.

K. Anstrom, D. Mark, L. Shaw, 2002, Obesity research.

Surrogate assessment of coronary artery disease patients' functional capacity.

D. Mark, T. Haney, I. Siegler, 1997, Social science & medicine.

Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables.

R. Coleman, F. Harrell, K. Lee, 1990, Circulation.

Painless exercise ST deviation on the treadmill: long-term prognosis.

Stephen D. Sisson, F. Harrell, K. Lee, 1989, Journal of the American College of Cardiology.

Surgical survival benefits for coronary disease patients with left ventricular dysfunction.

F. Harrell, K. Lee, R. Califf, 1988, Circulation.

Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery.

M A Hlatky, F E Harrell, F. Harrell, 1988, Journal of the American College of Cardiology.

Tying clinical research to patient care by use of an observational database.

F. Harrell, K. Lee, R. Califf, 1984, Statistics in medicine.

Noninvasive testing is done only in low risk patients with unstable angina and non-Q-wave Myocardial Infarction (MI): Results from GUSTO-IIa

R. Califf, D. Mark, E. Topol, 1996 .

Expert Consensus Document 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents

R. Morin, D. Berman, M. Budoff, 2010 .

Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies.

D. Mark, B. Gersh, E. Ohman, 2008, American heart journal.

Medical economics and the assessment of value in cardiovascular medicine: Part II.

D. Mark, M. Hlatky, 2002, Circulation.

Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention.

Kevin L. Thomas, D. Mark, C. Yancy, 2008, American heart journal.

The Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization: Rationale and Design of the PRECISE Trial.

E. Yow, D. Mark, G. Stone, 2021, American heart journal.

Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity

Sean M. O'Brien, M. Keltai, C. Held, 2021, Circulation.

Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip

J Thomas Bigger, Daniel B Mark, D. Mark, 2008, Circulation.

Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.

K. Anstrom, I. Piña, C. O'connor, 2018, Journal of the American College of Cardiology.

Non-evidence-based ICD implantations in the United States.

Sana M. Al-Khatib, Gillian D. Sanders, Lesley H. Curtis, 2011, JAMA.

The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.

Mark Donahue, Tariq Ahmad, Faiez Zannad, 2014, American heart journal.

Long‐term outcomes of mitral regurgitation by type and severity

Matthew Phelan, Daniel B. Mark, Linda K. Shaw, 2018, American heart journal.

Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials.

K. Anstrom, D. Mark, A. Moss, 2013, JAMA.

Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy

D. Mark, M. Gold, O. Costantini, 2008, Circulation.

Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery.

R H Jones, F E Harrell, F. Harrell, 1991, Circulation.

Primary prevention implantable cardioverter-defibrillators and survival in older women.

K. Anstrom, D. Mark, G. Sanders, 2015, JACC. Heart failure.

The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly.

E. DeLong, D. Mark, J. Jollis, 1998, Journal of the American College of Cardiology.

Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure).

I. Piña, M. Drazner, D. Mark, 2014, JACC. Heart failure.

Report of the Substudy Assessing the Impact of Neurocognitive Function on Quality of Life 5 Years After Cardiac Surgery

W. White, D. Mark, J. Blumenthal, 2001, Stroke.

Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy

M. Drazner, D. Mark, H. White, 2018, Open Heart.

Quality-of-Life Outcomes With Coronary Artery Bypass Graft Surgery in Ischemic Left Ventricular Dysfunction

K. Anstrom, D. Mark, J. Spertus, 2014, Annals of Internal Medicine.

Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial.

K. Anstrom, D. Mark, J. Spertus, 2009, American heart journal.

Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT)

D. Mark, S. Al‐Khatib, A. Hellkamp, 2008, Journal of cardiovascular electrophysiology.

Revascularization in stable coronary disease: evidence and uncertainties

D. Mark, B. Gersh, D. Katritsis, 2018, Nature Reviews Cardiology.

No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

D. Mark, F. Marchlinski, R. Yee, 2008, Journal of the American College of Cardiology.

Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT).

G. Lamas, D. Mark, M. Sweeney, 2007, Heart rhythm.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design

Sean M. O'Brien, L. Shaw, D. Mark, 2018, American heart journal.

Clinical correlates and prognostic significance of type A behavior and silent myocardial ischemia on the treadmill.

F. Harrell, D. Pryor, D. Mark, 1989, The American journal of cardiology.

Job strain and the prevalence and outcome of coronary artery disease.

K. Lee, R. Califf, D. Pryor, 1995, Circulation.

The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

G. Guyatt, C. O'connor, D. Mark, 2008, Chest.

NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF.

K. Anstrom, E. Yow, E. Leifer, 2019, JACC. Heart failure.

Implications of cost in treatment selection for patients with coronary heart disease.

D. Mark, 1996, The Annals of thoracic surgery.

Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study.

K. Anstrom, D. Mark, K. Schulman, 2007, American heart journal.

Costs for heart failure with normal vs reduced ejection fraction.

K. Anstrom, D. Mark, K. Schulman, 2006, Archives of internal medicine.

Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues.

R. Califf, D. Mark, E. Ohman, 2008, American heart journal.

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.

Kevin J. Anstrom, Daniel B. Mark, Tariq Ahmad, 2014, JACC. Heart failure.

Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA

C. Held, K. Anstrom, D. Mark, 2022, Circulation.

How Reliable are Patient‐Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies

K. Anstrom, D. Mark, E. Peterson, 2016, Journal of the American Heart Association.

Economics of treating heart failure.

D. Mark, 1997, The American journal of cardiology.

Perceived Social Support as a Predictor of Mortality in Coronary Patients: Effects of Smoking, Sedentary Behavior, and Depressive Symptoms

D. Mark, B. Brummett, I. Siegler, 2005, Psychosomatic medicine.

Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease.

D. Mark, B. Brummett, I. Siegler, 2003, The American journal of cardiology.

Impact of lung transplantation on recipient quality of life: a serial, prospective, multicenter analysis through the first posttransplant year.

D. Mark, D. Vock, K. Pieper, 2013, Chest.

Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT).

G. Lamas, K. Anstrom, D. Mark, 2020, Journal of diabetes and its complications.

Differential outcomes with edetate disodium-based treatment among stable post anterior vs. non-anterior myocardial infarction patients.

G. Lamas, R. Roberts, D. Mark, 2020, Cardiovascular revascularization medicine : including molecular interventions.

The Effect of an EDTA-based Chelation Regimen on Patients With Diabetes Mellitus and Prior Myocardial Infarction in the Trial to Assess Chelation Therapy (TACT)

G. Lamas, D. Mark, Y. Rosenberg, 2014, Circulation. Cardiovascular quality and outcomes.

Absence of bilateral vision loss from amiodarone: a randomized trial.

George A. Johnson, D. Mark, J. Mindel, 2007, American heart journal.

Depressive Symptoms and Survival of Patients With Coronary Artery Disease

D. Mark, B. Brummett, I. Siegler, 2000, Psychosomatic medicine.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

Daniel B. Mark, Gust H. Bardy, D. Mark, 2005 .

Disparities in Cardiovascular Research Output and Disease Outcomes among High-, Middle- and Low-Income Countries – An Analysis of Global Cardiovascular Publications over the Last Decade (2008–2017)

D. Mark, G. Bloomfield, A. Mokdad, 2021, Global heart.

Fundamentals of economic analysis

D. Mark, T. Simons, 1999 .

Prospective Study of Perceived Stress in Cardiac Patients

D. Mark, B. Brummett, I. Siegler, 2004, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Cardiovascular disease on a global scale: defining the path forward for research and practice.

Robert M Califf, Paul W Armstrong, Daniel B Mark, 2007, European heart journal.

Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trial

Neha J. Pagidipati, D. Mark, P. Pellikka, 2016, American heart journal.

Depression as a risk factor for mortality after coronary artery bypass surgery

W. White, D. Mark, J. Blumenthal, 2003, The Lancet.

G. Fonarow, L. Shaw, Jeffrey L. Anderson, 2014, Circulation.

Home use of automated external defibrillators for sudden cardiac arrest.

Warren Smith, Douglas L Packer, Paul Dorian, 2008, The New England journal of medicine.

The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial.

D. Mark, E. Steyerberg, P. Douglas, 2017, JACC. Cardiovascular imaging.

34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective?

L. Shaw, D. Mark, M. Lauer, 2003, Journal of the American College of Cardiology.

Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index.

M A Hlatky, R. Califf, D. Pryor, 1991, The American journal of cardiology.

What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial.

Eric L Eisenstein, Salim Yusuf, Daniel B Mark, 2006, Journal of cardiac failure.

Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial

K. Anstrom, D. Mark, K. Alexander, 2016, Circulation.

Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials

P. Kudenchuk, D. Mark, L. Inoue, 2015, Circulation. Cardiovascular quality and outcomes.

Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates.

George A. Johnson, D. Mark, D. Linker, 2018, JACC. Clinical electrophysiology.

The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial.

C. O'connor, K. Steinhauser, J. Tulsky, 2021, Journal of cardiac failure.

Outcomes and costs within a disease management program for advanced congestive heart failure.

R. Califf, D. Mark, K. Schulman, 1998, American heart journal.

Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions.

Jeroen J. Bax, D. Kass, D. Mark, 2005, Journal of the American College of Cardiology.

Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

George A. Johnson, M. Walsh, D. Mark, 2014, Journal of the American College of Cardiology.

Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men.

Christopher O'Connor, C. O'connor, D. Mark, 2002, The American journal of cardiology.

Clinical Cardiology, and Council on Cardiovascular Disease in the Young on behalf of the American Heart Association Council on Cardiovascular Nursing, Council on

Paul J. Wang, D. Mark, S. Pressler, 2013 .

SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.

Wan-Tai M. Au-Yeung, Per G Reinhall, Daniel B Mark, 2015, Heart rhythm.

Quality still doesn't pay in heart failure management.

D. Mark, D. Whellan, 2003, Journal of cardiac failure.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches–Chronic Kidney Disease (ISCHEMIA‐CKD): Rationale and design

Sean M. O'Brien, J. Fleg, D. Mark, 2018, American heart journal.

The economics of heart failure.

D. Mark, Dhruv S. Kazi, 2013, Heart failure clinics.

Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL‐HF trial

K. Anstrom, C. O'connor, K. Steinhauser, 2016, American heart journal.

Quality of life in patients with implantable cardioverter–defibrillator: systematic review of randomized controlled trials

R. Passman, D. Mark, C. Rodrigues, 2018, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial.

D. Mark, A. Hellkamp, G. Bardy, 2013, Heart rhythm.

Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.

D. Mark, P. Armstrong, C. Granger, 2004, Canadian Journal of Cardiology.

Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial

Michael T. Lu, D. Mark, P. Douglas, 2018, JAMA cardiology.

Predictive Model for High-Risk Coronary Artery Disease: Insights From the PROMISE Trial

D. Mark, J. Tardif, P. Douglas, 2019, Circulation. Cardiovascular imaging.

Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

D. Mark, A. Hellkamp, G. Bardy, 2008, American heart journal.

Initial Invasive or Conservative Strategy for Stable Coronary Disease.

Sean M. O'Brien, F. Harrell, M. Keltai, 2020, The New England journal of medicine.

Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.

Andrew R Willan, Anastasios A Tsiatis, Ameet Bakhai, 2005, American heart journal.

Association of Neurocognitive Function and Quality of Life 1 Year After Coronary Artery Bypass Graft (CABG) Surgery

D. Mark, J. Blumenthal, M. Newman, 2006, Psychosomatic medicine.

Comparing risk-adjustment methods for provider profiling.

E. DeLong, D. DeLong, D. Mark, 1998, Statistics in medicine.

Measuring and improving quality of care : A report from the american heart Association/American college of cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke

B. McNeil, P. Wolf, E. DeLong, 2000, Stroke.

Exploring options for improving healthcare.

D. Mark, K. Schulman, D. Mendelson, 2004, American heart journal.

The progression of congestive heart failure over the course of the sudden cardiac death in heart failure trial (SCD-HeFT)

D. Mark, M. Domanski, R. Boineau, 2005 .

Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.

George A. Johnson, K. Anstrom, D. Mark, 2020, Journal of the American College of Cardiology.

Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI).

D. Mark, K. Eagle, M. Hlatky, 2001, The American journal of medicine.

Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction

G. Lamas, D. Mark, H. White, 2011, Circulation.

Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries.

F. Harrell, K. Lee, R. Califf, 1986, The American journal of cardiology.

Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial

R. Roberts, D. Mark, C. Granger, 2017, JAMA cardiology.

Survival After Invasive or Conservative Management of Stable Coronary Disease

Sean M. O'Brien, D. Mark, Y. Rosenberg, 2022, Circulation.

Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose.

Michael T. Lu, R. Roberts, D. Mark, 2017, Journal of cardiovascular computed tomography.

Comparison of time domain and frequency domain variables from the signal-averaged electrocardiogram: a multivariable analysis.

R. Califf, P. Wolf, D. Mark, 1988, Journal of the American College of Cardiology.

Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial

Michael T. Lu, D. Mark, M. Ferencik, 2021, JAMA Cardiology.

Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia

Neha J. Pagidipati, D. Mark, J. Tardif, 2019, Heart.

Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease.

Neha J. Pagidipati, Michael T. Lu, D. Mark, 2019, Journal of the American College of Cardiology.

Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial

Neha J. Pagidipati, Michael T. Lu, D. Mark, 2017, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America

D. Mark, L. Cooper, P. Douglas, 2017, BMJ Open.

Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial

E. Yow, D. Mark, P. Douglas, 2017, American heart journal.

Quality-of-Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE Randomized Trial

K. Anstrom, D. Mark, L. Cooper, 2016, Circulation.

Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial.

Neha J. Pagidipati, D. Mark, P. Pellikka, 2016, JACC. Cardiovascular imaging.

Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.

Sean M. O'Brien, C. Held, D. Mark, 2023, Journal of the American College of Cardiology.

Cardiovascular Health: A Challenge for Midlife

D. Mark, I. Siegler, B. H. Kaplan, 1999 .

Acute and 1‐Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE‐ACS Registry

D. Mark, E. Peterson, Tracy Y. Wang, 2019, Journal of the American Heart Association.

Absence of sex bias in the referral of patients for cardiac catheterization.

R. Califf, D. Pryor, E. DeLong, 1994, The New England journal of medicine.

Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.

F Van de Werf, T D Thompson, E L Eisenstein, 2000, The New England journal of medicine.

Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial.

Udo Hoffmann, Pamela S Douglas, Michael T. Lu, 2017, JACC. Cardiovascular imaging.

Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

K. Anstrom, D. Mark, G. Sanders, 2014, JAMA.

901-84 Prognostic Value of Right Heart Catheterization Hemodynamic Data in Surgically Treated Patients with Coronary Artery Disease

F. Harrell, R. Califf, C. O'connor, 1995 .

Atrial Fibrillation Burden and Heart Failure: Data from 39,710 Individuals with Cardiac Implanted Electronic Devices.

Emily C. O'Brien, D. Mark, J. Piccini, 2021, Heart rhythm.

Moderators of the effect of social support on depressive symptoms in cardiac patients.

D. Mark, B. Brummett, I. Siegler, 2000, The American journal of cardiology.

Prospective study of associations among positive emotion and functional status in older patients with coronary artery disease.

D. Mark, M. Morey, B. Brummett, 2009, The journals of gerontology. Series B, Psychological sciences and social sciences.

Intraoperative Magnesium Administration Does Not Improve Neurocognitive Function After Cardiac Surgery

Jeffrey N. Browndyke, W. White, D. Mark, 2013, Stroke.

Medical, psychological and social correlates of work disability among men with coronary artery disease.

R. Califf, D. Pryor, D. Mark, 1986, The American journal of cardiology.

Social support and quality of life in patients with coronary artery disease

D. Mark, H. Bosworth, B. Brummett, 2004, Quality of Life Research.

Coronary Catherization Patient and Wife's Perceptions of Social Support: Effects Due to Characteristics of Recipient, Provider, and Their Interaction

D. Mark, I. Siegler, Redford B Williams, 2000, International journal of aging & human development.

Recovery expectations and long-term prognosis of patients with coronary heart disease.

D. Mark, B. Brummett, S. Boyle, 2011, Archives of internal medicine.

Off-pump bypass surgery--ready for the big dance?

D. Mark, E. Peterson, 2004, JAMA.

Enhancing recovery in coronary heart disease (ENRICHD): baseline characteristics.

C. O'connor, D. Mark, M. Mckee, 2001, The American journal of cardiology.

Re-evaluating the volume-outcome relationship in hemodialysis patients.

K. Anstrom, D. Mark, J. Stafford, 2008, Health policy.

Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).

R. Califf, D. Mark, P. Armstrong, 2000, The American journal of cardiology.

Fixing the heart: must the brain pay the price?

D. Mark, J. Blumenthal, M. Newman, 2004, Circulation.

Ratings of positive and depressive emotion as predictors of mortality in coronary patients.

D. Mark, B. Brummett, S. Boyle, 2005, International journal of cardiology.

The association between self-rated health and mortality in a well-characterized sample of coronary artery disease patients.

R B Williams, D. Mark, H. Bosworth, 1999, Medical care.

The Relationship between Self-Rated Health and Health Status among Coronary Artery Patients

D. Mark, H. Bosworth, B. Brummett, 1999, Journal of aging and health.

Depression as risk factor for mortality after coronary artery bypass surgery

D. Mark, J. Blumenthal, M. Newman, 2003, The Lancet.

AB24-2: Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HeFT

D. Mark, A. Hellkamp, G. Bardy, 2006 .

Assessing Quality of Life and Medical Care in Chronic Angina: An Internet Survey

K. Anstrom, D. Mark, K. Alexander, 2016, Interactive journal of medical research.

Neurocognitive dysfunction and quality of life after cardiac surgery

D. Mark, J. Blumenthal, M. Newman, 2000 .

DISCORDANCES BETWEEN PREDICTED AND ACTUAL RISK OF ADVERSE EVENTS IN OBESE PATIENTS WITH SUSPECTED CARDIAC ISCHEMIA: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN)

Neha J. Pagidipati, D. Mark, J. Tardif, 2017 .

Variability in cost of coronary bypass surgery in New York State: potential for cost savings.

E. DeLong, D. Mark, E. Hannan, 2002, American heart journal.

The way of the future redux.

R. Califf, D. Pryor, D. Mark, 1995, The American journal of cardiology.

Design of the Trial to Assess Chelation Therapy (TACT).

G. Lamas, D. Mark, R. Nahin, 2012, American heart journal.

Implications of Abnormal Exercise Electrocardiography With Normal Stress Echocardiography.

Joseph A. Sivak, A. Dunning, D. Mark, 2020, JAMA internal medicine.

Economic Outcomes with Anatomic versus Functional Diagnostic Testing for Coronary Artery Disease

D. Mark, L. Cooper, P. Cowper, 2022 .

Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients.

D. Mark, A. Hellkamp, G. Bardy, 2014, Journal of the American College of Cardiology.

Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes Vytorin Efficacy International Trial)

D. Mark, R. Giugliano, E. Braunwald, 2017, Circulation. Cardiovascular quality and outcomes.

Geographic variation in resource use for coronary artery bypass surgery. IHD Port Investigators.

D. Pryor, E. DeLong, D. Mark, 1997, Medical care.

ISCHEMIA trial update.

D. Mark, J. Spertus, 2019, American heart journal.

Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.

R. Califf, D. Mark, S. Connolly, 2005, American heart journal.

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes.

A A Tsiatis, E J Topol, R. Califf, 2000, Circulation.

Long-term clinical outcomes following coronary stenting.

R. Califf, K. Anstrom, D. Mark, 2008, Archives of internal medicine.

Pheochromocytoma presenting as fever of unknown origin.

D. Mark, S. Martin, Ravi Karra, 2011, The American journal of medicine.

Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure.

Eric L Eisenstein, Daniel B Mark, D. Mark, 2002, American heart journal.

(8th Edition) Evidence-Based Clinical Practice Guidelines American College of Chest Physicians Allocation and Economic Considerations: Strategies for Incorporating Resource

D. Mark, D. Matchar, 2008 .

Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study).

D. Mark, B. Chaitman, G. Knatterud, 1999, The American journal of cardiology.

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing)

E. Antman, D. Mark, J. Alpert, 2002 .

Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)

E. Antman, D. Mark, J. Alpert, 2002 .

EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy.

G. Lamas, D. Mark, Y. Rosenberg, 2014, American heart journal.

A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease

R. Califf, D. Mark, E. Topol, 1993 .

Cardiac computed tomographic angiography what's the prognosis?

D. Mark, D. Kong, 2010, Journal of the American College of Cardiology.

Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.

K. Anstrom, K. Steinhauser, J. Tulsky, 2017, Journal of the American College of Cardiology.

Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial.

D. Mark, K. Alexander, J. Spertus, 2023, Journal of the American College of Cardiology.

Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction.

E. B. Carlson, R. Califf, D. Pryor, 1988, Journal of the American College of Cardiology.

3 : Decision-Making in Clinical Medicine

D. Mark, J. Wong, 2017 .

Patterns of Change in Individual Domains of the Kansas City Cardiomyopathy Questionnaire with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HF.

K. Anstrom, C. O'connor, J. Tulsky, 2021, Journal of cardiac failure.

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

Dave L Dixon, D. Mark, L. Newby, 2023, Journal of the American College of Cardiology.

The economics of heart failure.

D. Mark, Dhruv S. Kazi, 2013, Heart failure clinics.

Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose.

Michael T. Lu, R. Roberts, D. Mark, 2017, Journal of cardiovascular computed tomography.

Quality of life with defibrillator therapy or amiodarone in heart failure.

A. Tsiatis, K. Anstrom, D. Mark, 2008, The New England journal of medicine.

Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.

Erry, Ames, oseph, 2001, The New England journal of medicine.

Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists.

D. Mark, E. Topol, S. Ellis, 2002, American Heart Journal.

Intraoperative Magnesium Administration Does Not Improve Neurocognitive Function After Cardiac Surgery

Jeffrey N. Browndyke, W. White, D. Mark, 2013, Stroke.

Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families: A Scientific Statement From the American Heart Association

D. Mark, S. Pressler, E. Schron, 2012, Circulation.

Home use of automated external defibrillators for sudden cardiac arrest.

Roger D. White, W. Toff, D. Mark, 2008, The New England journal of medicine.

Outcomes of anatomical versus functional testing for coronary artery disease.

E. Yow, D. Mark, M. Krucoff, 2015, The New England journal of medicine.

Downstream testing and subsequent procedures after coronary computed tomographic angiography following coronary stenting in patients ≥65 years of age.

D. Mark, P. Douglas, F. Masoudi, 2012, The American journal of cardiology.

The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial.

D. Mark, E. Steyerberg, M. Hunink, 2017, JACC. Cardiovascular imaging.

Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention.

J. Messenger, D. Mark, G. Stone, 2014, Journal of the American College of Cardiology.

Rationale and design of the Home Automatic External Defibrillator Trial (HAT).

Roger D. White, W. Toff, D. Mark, 2008, American heart journal.

Faha, R. Morin, D. Berman, 2022 .

Do income level and race influence survival in patients receiving hemodialysis?

K. Anstrom, D. Mark, J. Stafford, 2009, The American journal of medicine.

Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?

Lurdes Y. T. Inoue, D. Mark, A. Kadish, 2017, Circulation.

Quality-of-Life Outcomes With a Disodium EDTA Chelation Regimen for Coronary Disease: Results From the Trial to Assess Chelation Therapy Randomized Trial

G. Lamas, K. Anstrom, D. Mark, 2014, Circulation. Cardiovascular quality and outcomes.

Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.

G. Lamas, D. Mark, R. Nahin, 2013, JAMA.

I. Piña, M. Drazner, D. Mark, 2014, JACC. Heart failure.

Economics of Glycoprotein IIb/IIIa Inhibition

Daniel B. Mark, D. Mark, 1999 .

Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

D. Mark, A. Hellkamp, G. Bardy, 2014, Journal of the American College of Cardiology.

Cardiac resynchronization therapy: Part 1--issues before device implantation.

Jeroen J. Bax, D. Kass, D. Mark, 2005, Journal of the American College of Cardiology.

PCV59 ECONOMIC ANALYSIS OF THE ENDEAVOR DRUG-ELUTING STENT VS. THE DRIVER BARE METAL STENT: RESULTS FROM THE ENDEAVOR II TRIAL

K. Anstrom, D. Mark, E. Eisenstein, 2009 .

Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.

K. Anstrom, K. Steinhauser, J. Tulsky, 2017, Journal of the American College of Cardiology.

D. Mark, J. Bigger, P. Kaufmann, 2008, Circulation.

Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial.

Michael T. Lu, D. Mark, M. Ferencik, 2021, JAMA cardiology.

Medical economics and the assessment of value in cardiovascular medicine: Part II.

D. Mark, M. Hlatky, 2002, Circulation.

Trade-offs and toss-ups: making revascularization decisions in carotid artery disease.

K. Anstrom, D. Mark, M. Patel, 2011, Journal of the American College of Cardiology.

Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.

George A. Johnson, D. Mark, D. Packer, 2008, Journal of the American College of Cardiology.

African Americans With Advanced Heart Failure Are More Likely to Die in a Health Care Facility Than at Home or in Hospice: An Analysis From the PAL-HF Trial.

K. Anstrom, C. O'connor, K. Steinhauser, 2019, Journal of cardiac failure.

Abstract 13116: Persistent Lack of Benefit of Late Revascularization of the Occluded Coronary Artery Post-MI - The Occluded Artery Trial (OAT) Long Term Results

G. Lamas, D. Mark, C. Buller, 2010 .

Interventional Cardiology Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction

G. Lamas, D. Mark, H. White, 2011 .

Abstract 17295: Health Economics in the PLATelet inhibition and Patient Outcomes (PLATO) Randomized Trial: Report on Within Trial Resource Use Patterns

D. Mark, L. Levin, L. Wallentin, 2010 .

Economic impact of new interventional therapies: are we asking the right questions?

D. Mark, D. Kong, 2004, Journal of the American College of Cardiology.

Reporting and representation of race/ethnicity in published randomized trials.

D. Mark, E. Peterson, L. Newby, 2009, American heart journal.